Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1-Year outcomes from a multicentre randomized trial

Neurourol Urodyn. 2021 Jan;40(1):475-482. doi: 10.1002/nau.24586. Epub 2020 Dec 1.

Abstract

Aims: To compare the effectiveness and safety of polypropylene (PP) and polyvinylidene fluoride (PVDF) transobturator tapes (TOT) for the treatment of female stress urinary incontinence (SUI).

Methods: This is a multicentre randomized trial. Women with SUI or stress-predominant mixed urinary incontinence and scheduled for a TOT procedure were randomized to PP or PVDF slings. The primary outcome was 1-year cure or improvement rate using composite criteria. Complications were also compared. Relationships with outcomes were analyzed using multivariable logistic regressions models.

Results: From April 2016 to January 2018 285 participants were randomized. PP and PVDF slings showed similar high cure or improvement rate (91.0% vs. 95.6%, p = .138). Improvement in validated questionnaires was also similar. PVDF slings were associated with a lower rate of de novo urgency incontinence (adjusted odds ratio = 0.35; 95% confidence interval = 0.15-0.80). We found no statistical differences in complications rates, although a higher incidence of long-term pain events were observed in the PP group. The study is underpowered to find differences in specific complications owing to the low number of events.

Conclusion: PP and PVDF TOTs are equally effective, although PVDF is associated with fewer cases of de novo urgency incontinence. Further studies are needed to give robust conclusions on safety profiles.

Keywords: PVDF; de novo urgency incontinence; midurethral sling; polypropylene; polyvinylidene fluoride; sling complications; stress urinary incontinence; suburethral sling; suburethral tape; transobturator.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polypropylenes / pharmacology
  • Polypropylenes / therapeutic use*
  • Polyvinyls / pharmacology
  • Polyvinyls / therapeutic use*
  • Surveys and Questionnaires
  • Treatment Outcome
  • Urinary Incontinence / drug therapy*
  • Urinary Incontinence / therapy*
  • Urinary Incontinence, Stress
  • Urologic Surgical Procedures / methods*

Substances

  • Polypropylenes
  • Polyvinyls
  • polyvinylidene fluoride